Literature DB >> 19483151

Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation.

Silvia Deaglio, Fabio Malavasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19483151      PMCID： PMC2688562          DOI： 10.3324/haematol.2009.006676

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  27 in total

Review 1.  CD40 activation: potential for specific immunotherapy in B-CLL.

Authors:  M von Bergwelt-Baildon; B Maecker; J Schultze; J G Gribben
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

Review 2.  Chronic lymphocytic leukaemia: a review of the immuno-architecture.

Authors:  S Rosati; Ph M Kluin
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

3.  Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

Authors:  U Klein; Y Tu; G A Stolovitzky; M Mattioli; G Cattoretti; H Husson; A Freedman; G Inghirami; L Cro; L Baldini; A Neri; A Califano; R Dalla-Favera
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

4.  Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.

Authors:  J Nilsson; O Söderberg; K Nilsson; A Rosén
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

5.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

6.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.

Authors:  Kathleen J Till; Ke Lin; Mirko Zuzel; John C Cawley
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

8.  Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA.

Authors:  Basile Stamatopoulos; Benjamin Haibe-Kains; Carole Equeter; Nathalie Meuleman; Anne Sorée; Cécile De Bruyn; Delphine Hanosset; Dominique Bron; Philippe Martiat; Laurence Lagneaux
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

9.  Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.

Authors:  Sonia López-Giral; Nuria E Quintana; María Cabrerizo; Manuel Alfonso-Pérez; Mónica Sala-Valdés; Valle Gómez Garcia De Soria; José María Fernández-Rañada; Elena Fernández-Ruiz; Cecilia Muñoz
Journal:  J Leukoc Biol       Date:  2004-05-20       Impact factor: 4.962

10.  Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.

Authors:  A Rosenwald; A A Alizadeh; G Widhopf; R Simon; R E Davis; X Yu; L Yang; O K Pickeral; L Z Rassenti; J Powell; D Botstein; J C Byrd; M R Grever; B D Cheson; N Chiorazzi; W H Wilson; T J Kipps; P O Brown; L M Staudt
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307
View more
  14 in total

Review 1.  Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.

Authors:  Adrian Wiestner
Journal:  Blood       Date:  2012-08-08       Impact factor: 22.113

Review 2.  CD38 and chronic lymphocytic leukemia: a decade later.

Authors:  Fabio Malavasi; Silvia Deaglio; Rajendra Damle; Giovanna Cutrona; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

3.  A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo.

Authors:  Davorka Messmer; Kymmy Lorrain; Karin Stebbins; Yalda Bravo; Nicholas Stock; Geraldine Cabrera; Lucia Correa; Austin Chen; Jason Jacintho; Nicholas Chiorazzi; Xiao Jie Yan; David Spaner; Peppi Prasit; Daniel Lorrain
Journal:  Mol Med       Date:  2015-06-09       Impact factor: 6.354

4.  The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

Authors:  Yair Herishanu; Patricia Pérez-Galán; Delong Liu; Angélique Biancotto; Stefania Pittaluga; Berengere Vire; Federica Gibellini; Ndegwa Njuguna; Elinor Lee; Lawrence Stennett; Nalini Raghavachari; Poching Liu; J Philip McCoy; Mark Raffeld; Maryalice Stetler-Stevenson; Constance Yuan; Richard Sherry; Diane C Arthur; Irina Maric; Therese White; Gerald E Marti; Peter Munson; Wyndham H Wilson; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

5.  ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.

Authors:  Colby M Chapman; Xiameng Sun; Mark Roschewski; Georg Aue; Mohamed Farooqui; Lawrence Stennett; Federica Gibellini; Diane Arthur; Patricia Pérez-Galán; Adrian Wiestner
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

6.  Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific manners.

Authors:  Byeongho Jung; Gerardo Ferrer; Pui Yan Chiu; Rukhsana Aslam; Anita Ng; Florencia Palacios; Michael Wysota; Martina Cardillo; Jonathan E Kolitz; Steven L Allen; Jacqueline C Barrientos; Kanti R Rai; Nicholas Chiorazzi; Barbara Sherry
Journal:  JCI Insight       Date:  2022-06-22

7.  CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.

Authors:  Sylvia Ganghammer; Evelyn Hutterer; Elisabeth Hinterseer; Gabriele Brachtl; Daniela Asslaber; Peter William Krenn; Tamara Girbl; Petra Berghammer; Roland Geisberger; Alexander Egle; Antonella Zucchetto; Anna Kruschinski; Valter Gattei; Alexandre Chigaev; Richard Greil; Tanja Nicole Hartmann
Journal:  Oncotarget       Date:  2015-05-20

8.  Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.

Authors:  Agata A Filip; Bogumiła Ciseł; Ewa Wąsik-Szczepanek
Journal:  Clin Exp Med       Date:  2013-12-12       Impact factor: 3.984

9.  Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia.

Authors:  Julio C Chavez; Eva Sahakian; Javier Pinilla-Ibarz
Journal:  Core Evid       Date:  2013-05-16

10.  Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy.

Authors:  S E M Herman; X Sun; E M McAuley; M M Hsieh; S Pittaluga; M Raffeld; D Liu; K Keyvanfar; C M Chapman; J Chen; J J Buggy; G Aue; J F Tisdale; P Pérez-Galán; A Wiestner
Journal:  Leukemia       Date:  2013-04-26       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.